News

StockStory.org on MSN7d
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?
Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling ...
Becker's Spine Review3d
Globus Medical’s top-paid execs in 2024
Globus Medical CEO Daniel Scavilla’s salary rose to $4.8 million in 2024, according to the company’s April 25 Securities and Exchange Commission proxy filing. Compensation packages for executives ...
Investor's Business Daily on MSN7d
Globus Medical Sees Relative Strength Rating Improve To 73
Decades of market research shows that the best-performing stocks often have an 80 or higher RS Rating in the early stages of ...
Globus Medical: Digesting Another Acquisition
Globus Medical, Inc. shines with strong Q4 results & Nevro acquisition, boosting its market position. Click here to find out ...
Yahoo Finance15d
Globus Medical Schedules First Quarter Earnings Release and Conference Call
Globus Medical AUDUBON, Pa., April 17, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the first ...
Globus Medical Inc.
Globus Medical Inc. stock grades by Barron's. View GMED fundamental and sentiment analysis powered by MarketGrader.
Yahoo Finance17d
Is The Market Rewarding Globus Medical, Inc. (NYSE:GMED) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
It is hard to get excited after looking at Globus Medical's (NYSE:GMED) recent performance, when its stock has declined 17% over the past three months. It seems that the market might have ...